Search results
Results from the WOW.Com Content Network
Multiple endocrine neoplasia, type 2, also called MEN 2, is a rare condition. It causes tumors in the thyroid and parathyroid glands, adrenal glands, lips, mouth, eyes and digestive tract. Genetic testing can find the changed gene that causes MEN 2. Health care providers can treat the health issues that gene may cause.
Multiple endocrine neoplasia type 2 (MEN 2) is a hereditary cancer syndrome associated primarily with tumors of the adrenal gland, thyroid and parathyroid. It is further classified into MEN2A and MEN2B.
Multiple endocrine neoplasia type 2 (MEN2): This is a genetic polyglandular (multiple glands) cancer syndrome. People with MEN2 will develop medullary thyroid cancer (carcinoma) and have an increased risk of developing other tumors that affect other glands in the endocrine system.
MEN 2 (Multiple Endocrine Neoplasia Syndrome type 2) is a group of diseases including a type of thyroid cancer called Medullary Thyroid Cancer (MTC). MEN2 is due to a change (mutation) in a gene called RET. This gene mutation can be found with a blood test for genetic testing.
Multiple endocrine neoplasia type 2 (also known as "Pheochromocytoma (codons 630 and 634) and amyloid producing medullary thyroid carcinoma", [1] "PTC syndrome," [1] and "Sipple syndrome" [1]) is a group of medical disorders associated with tumors of the endocrine system.
Multiple endocrine neoplasia (MEN) syndromes are inherited genetic disorders that cause endocrine (gland) tumors. Endocrine surgeon Lilah Morris-Wiseman, M.D., explains the diagnosis, causes and treatment for multiple endocrine neoplasia.
To diagnose multiple endocrine neoplasia, type 2, also called MEN 2, your health care provider will do a physical exam. They will look at your medical history and family history. They also will do genetic testing to see if you have a gene change that causes MEN 2 .
Multiple endocrine neoplasia, type 2A (MEN 2A) is an autosomal dominant syndrome characterized by medullary carcinoma of the thyroid, pheochromocytoma, parathyroid hyperplasia or adenomas (causing hyperparathyroidism), and occasionally cutaneous lichen amyloidosis. Clinical features depend on the glandular elements affected.
MEN 2 (Multiple Endocrine Neoplasia Syndrome type 2) is a group of diseases including a type of thyroid cancer called Medullary Thyroid Cancer (MTC). MEN2 is due to a change (mutation) in a gene called RET. This gene mutation can be found with a blood test for genetic testing.
Multiple endocrine neoplasia 2 (MEN2) syndrome is a rare, inherited disorder that affects the endocrine glands or organs. MEN2 syndrome usually causes thyroid gland, parathyroid gland, or adrenal gland tumors. The tumors may be benign (not cancer) or malignant (cancer).